USPTO serial 98812438
GUUD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 11, 2025
- Examiner
- MAI, TINA HSIN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GUUD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Monterrey, Nuevo Leon, MX
Monterrey, Nuevo Leon, MX
Monterrey, Nuevo Leon, MX
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Vivian Ortiz-Ponce
Vivian Ortiz-Ponce PEREZ-GUERRERO LLCPO Box 9024163San Juan, PR 00902-4163United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for use in the treatment of metabolic syndrome, obesity and overweight; preparations for medical and veterinary use for use in the treatment of metabolic syndrome, obesity and overweight; hygienic and sanitary preparations for medical use for treatment of metabolic syndrome, obesity and overweight; dietetic food and beverages for medical or veterinary use for use in the treatment of metabolic syndrome, obesity and overweight; food supplements for persons or animals; capsules for medicines, sold empty for pharmaceuticals; medicines for constipation, namely, dragées, for use in the treatment of metabolic syndrome, obesity and overweight; non-steroidal antiinflammatory medicines for use in the treatment of metabolic syndrome, obesity and overweight; antifungal medicines; anti-malarial medicines; anti-pyretic medicines; Medicated soap for perspiration; anti-tumor medicines; antitussive medicines; cytostatic medicines for medical use; allergy medicines; diarrhea medicines; non-prescription medicines for use in the treatment of metabolic syndrome, obesity and overweight; medicines for adjusting the menstrual cycle; medicine for alleviating allergies; medicines for alleviating pain; acne medicines; medicines for alleviating burns; medicines for the treatment of gastrointestinal diseases; medicines for the prevention of puerperal fever; cough medicines; medicines for medical use for use in the treatment of metabolic syndrome, obesity and overweight; medicines for dental use for use in the treatment of metabolic syndrome, obesity and overweight; medicines for veterinary use for use in the treatment of metabolic syndrome, obesity and overweight serotherapeutic medicines; transdermal patch with medicine featuring preparations for the treatment of metabolic syndrome, obesity and overweight; patches containing medicines featuring preparations for the treatment of metabolic syndrome, obesity and overweight; preparations for use as medicated additives for food for human consumption for use in the treatment of metabolic syndrome, obesity and overweight; sulfonamides as medicines; tonics, namely, medicinal drinks; medicines for alleviating constipation; diagnostic agents for pharmaceutical use for use in the treatment of metabolic syndrome, obesity and overweight; milk ferments for pharmaceutical use; hormone preparations for pharmaceutical use for use in the treatment of metabolic syndrome, obesity and overweight; sunburn products for pharmaceutical use for treating sunburn; capsules for pharmaceutical use, sold empty for pharmaceuticals; tablets for pharmaceutical use, sold empty for pharmaceuticals; cytostatic preparations for pharmaceutical use; amino acid preparations for pharmaceutical use; analgesics for pharmaceutical use; bacteriological preparations for pharmaceutical use; body creams for pharmaceutical use for use in the treatment of metabolic syndrome, obesity and overweight; body gels for pharmaceutical use for use in the treatment of metabolic syndrome, obesity and overweight | ACTIVE | — |
| 009 | Downloadable mobile device applications for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; Downloadable software applications for mobile telephones for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; downloadable software applications for use with mobile devices for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; Downloadable software and software applications for mobile devices for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; downloadable mobile applications for use with portable computer devices for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; downloadable mobile applications for information management; Downloadable computer application software for mobile phones for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; downloadable software being part of a medical device for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; Downloadable computer programs relating to the medical field for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; scales | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GARCIA SADA, FERNANDO
- Other trademarks owned by GARCIA SADA, FERNANDO
- Other trademarks owned by GARCIA SADA, FERNANDO
- Other trademarks in Class 005
- Other trademarks in Class 009
- Similar marks named GUUD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 11, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 11, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 23, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 23, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 17, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 24, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 6, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 5, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 30, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 30, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 23, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 22, 2025 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 22, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 21, 2024 | NWAP | NEW APPLICATION ENTERED | — |